73 related articles for article (PubMed ID: 11955618)
1. Inhibiting transcription factor/DNA complexes using fluorescent microgonotropens (FMGTs).
White CM; Satz AL; Gawron LS; Bruice TC; Beerman TA
Biochim Biophys Acta; 2002 Feb; 1574(1):100-8. PubMed ID: 11955618
[TBL] [Abstract][Full Text] [Related]
2. Inhibition of transcription factor-DNA complexes and gene expression by a microgonotropen.
White CM; Satz AL; Bruice TC; Beerman TA
Proc Natl Acad Sci U S A; 2001 Sep; 98(19):10590-5. PubMed ID: 11535831
[TBL] [Abstract][Full Text] [Related]
3. Synthesis of fluorescent microgonotropens (FMGTs) and their interactions with dsDNA.
Satz AL; Bruice TC
Bioorg Med Chem; 2000 Aug; 8(8):1871-80. PubMed ID: 11003131
[TBL] [Abstract][Full Text] [Related]
4. Evaluation of the effectiveness of DNA-binding drugs to inhibit transcription using the c-fos serum response element as a target.
White CM; Heidenreich O; Nordheim A; Beerman TA
Biochemistry; 2000 Oct; 39(40):12262-73. PubMed ID: 11015205
[TBL] [Abstract][Full Text] [Related]
5. Recognition in the minor groove of double-stranded DNA by microgonotropens.
Satz AL; Bruice TC
Acc Chem Res; 2002 Feb; 35(2):86-95. PubMed ID: 11851386
[TBL] [Abstract][Full Text] [Related]
6. Modulation of topoisomerase II catalytic activity by DNA minor groove binding agents distamycin, Hoechst 33258, and 4',6-diamidine-2-phenylindole.
Woynarowski JM; McHugh M; Sigmund RD; Beerman TA
Mol Pharmacol; 1989 Feb; 35(2):177-82. PubMed ID: 2465485
[TBL] [Abstract][Full Text] [Related]
7. Transcriptional regulation of topoisomerase II alpha at confluence and pharmacological modulation of expression by bis-benzimidazole drugs.
Tolner B; Hartley JA; Hochhauser D
Mol Pharmacol; 2001 Apr; 59(4):699-706. PubMed ID: 11259613
[TBL] [Abstract][Full Text] [Related]
8. Effects of minor groove binding drugs on camptothecin-induced DNA lesions in L1210 nuclei.
McHugh MM; Sigmund RD; Beerman TA
Biochem Pharmacol; 1990 Feb; 39(4):707-14. PubMed ID: 1689578
[TBL] [Abstract][Full Text] [Related]
9. Involvement of DNA topoisomerase II in the selective resistance of a mammalian cell mutant to DNA minor groove ligands: ligand-induced DNA-protein crosslinking and responses to topoisomerase poisons.
Smith PJ; Bell SM; Dee A; Sykes H
Carcinogenesis; 1990 Apr; 11(4):659-65. PubMed ID: 2157558
[TBL] [Abstract][Full Text] [Related]
10. DNA bending in the ternary nucleoprotein complex at the c-fos promoter.
Sharrocks AD; Shore P
Nucleic Acids Res; 1995 Jul; 23(13):2442-9. PubMed ID: 7630721
[TBL] [Abstract][Full Text] [Related]
11. Crystal structure of a ternary SAP-1/SRF/c-fos SRE DNA complex.
Mo Y; Ho W; Johnston K; Marmorstein R
J Mol Biol; 2001 Nov; 314(3):495-506. PubMed ID: 11846562
[TBL] [Abstract][Full Text] [Related]
12. C/EBP beta and Elk-1 synergistically transactivate the c-fos serum response element.
Hanlon M; Bundy LM; Sealy L
BMC Cell Biol; 2000; 1():2. PubMed ID: 11151091
[TBL] [Abstract][Full Text] [Related]
13. Effect of minor groove binding drugs on mammalian topoisomerase I activity.
McHugh MM; Woynarowski JM; Sigmund RD; Beerman TA
Biochem Pharmacol; 1989 Jul; 38(14):2323-8. PubMed ID: 2473754
[TBL] [Abstract][Full Text] [Related]
14. Ternary complex factors Elk-1 and Sap-1a mediate growth hormone-induced transcription of egr-1 (early growth response factor-1) in 3T3-F442A preadipocytes.
Clarkson RW; Shang CA; Levitt LK; Howard T; Waters MJ
Mol Endocrinol; 1999 Apr; 13(4):619-31. PubMed ID: 10194767
[TBL] [Abstract][Full Text] [Related]
15. A microgonotropen pentaaza pentabutylamine and its interactions with DNA.
Sengupta D; Blaskó A; Bruice TC
Bioorg Med Chem; 1996 Jun; 4(6):803-13. PubMed ID: 8818229
[TBL] [Abstract][Full Text] [Related]
16. Downregulation of c-fos gene transcription in cells transformed by E1A and cHa-ras oncogenes: a role of sustained activation of MAP/ERK kinase cascade and of inactive chromatin structure at c-fos promoter.
Kukushkin AN; Abramova MV; Svetlikova SB; Darieva ZA; Pospelova TV; Pospelov VA
Oncogene; 2002 Jan; 21(5):719-30. PubMed ID: 11850800
[TBL] [Abstract][Full Text] [Related]
17. Role of specific response elements of the c-fos promoter and involvement of intermediate transcription factor(s) in the induction of Sertoli cell differentiation (transferrin promoter activation) by the testicular paracrine factor PModS.
Whaley PD; Chaudhary J; Cupp A; Skinner MK
Endocrinology; 1995 Jul; 136(7):3046-53. PubMed ID: 7789331
[TBL] [Abstract][Full Text] [Related]
18. Structure of the elk-1-DNA complex reveals how DNA-distal residues affect ETS domain recognition of DNA.
Mo Y; Vaessen B; Johnston K; Marmorstein R
Nat Struct Biol; 2000 Apr; 7(4):292-7. PubMed ID: 10742173
[TBL] [Abstract][Full Text] [Related]
19. Hoechst 33342 induces apoptosis and alters tata box binding protein/DNA complexes in nuclei from BC3H-1 myocytes.
Zhang X; Kiechle FL
Biochem Biophys Res Commun; 1998 Jul; 248(1):18-21. PubMed ID: 9675078
[TBL] [Abstract][Full Text] [Related]
20. Molecular characterization of the B-box protein-protein interaction motif of the ETS-domain transcription factor Elk-1.
Ling Y; Lakey JH; Roberts CE; Sharrocks AD
EMBO J; 1997 May; 16(9):2431-40. PubMed ID: 9171356
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
